Bevacizumab beyond Progression for Newly Diagnosed Glioblastoma (BIOMARK): Phase II Safety, Efficacy and Biomarker Study
暂无分享，去创建一个
Hideo Nakamura | T. Shibata | M. Nagane | K. Ichimura | Y. Arai | Y. Arakawa | A. Mukasa | R. Nishikawa | S. Morita | T. Wakabayashi | T. Ohnishi | Ritsuko Onuki | M. Nakada | T. Uzuka | Mamoru Kato | Shota Tanaka | Y. Narita | H. Yokoo | Shigeki Aoki | T. Aoki | K. Ishizawa | K. Satomi | S. Shibui | A. Tomiyama | M. Matsutani | Mai Honda-Kitahara | Hiroyoshi Suzuki | D. Narushima | Shota Tanaka | H. Suzuki